Soleno Therapeutics Inc.
Redwood City, CA Part of Neurocrine Biosciences, Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
San Diego, CA
GMQSH4CZ7EC9
-
Parent
San Diego, CA
GMQSH4CZ7EC9
- SAM.gov registration date
- Physical address
- 100 Marine Pkwy Suite 400, Redwood City, CA 94065, USA
- Website
- soleno.life
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Acer Therapeutics Inc. | Boston, MA | 456110 Pharmacies and Drug Retailers |
| Ionis Pharmaceuticals, Inc. | Carlsbad, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Mirum Pharmaceuticals, Inc. | San Mateo, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Day One Biopharmaceuticals, Inc. | Brisbane, CA | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Soleno Therapeutics Inc. is a for-profit corporate entity based in Redwood City, California, specializing in pharmaceutical and medical product manufacturing. Registered in SAM.gov since January 2014 with a registration valid through June 2026, the company appears to focus on developing and supplying pharmaceutical and hematology-related products to federal agencies. While specific details about the company's core business are not provided in the award data, its federal contract history suggests a strong orientation toward medical product development and distribution.
The company has been awarded three significant federal contract indefinite delivery vehicles (IDVs) across multiple federal agencies. Two contracts are with the Veterans Integrated Service Network 12 (VISN 12) under the Federal Supply Schedule, with one being a $225,000 contract for drugs, pharmaceuticals, and hematology-related products valid through July 31, 2030, and another interim agreement valued at $25,000 through October 31, 2025. A third contract is a Blanket Purchase Agreement (BPA) with the National Acquisition Center, valued at $2,500,000 and running through May 19, 2026. These contracts are primarily situated under the Pharmaceuticals and Drugs (FSS-61-IB) parent GSA Schedule, focusing on procuring medical and pharmaceutical products for veterans' healthcare services. None of the contracts utilize set-asides, indicating Soleno Therapeutics competes on an open market basis across these federal procurement vehicles.
Quick answers
Is Soleno Therapeutics Inc. registered in SAM.gov?
Yes. Soleno Therapeutics Inc.'s SAM.gov registration is active through September 10, 2027.
What is Soleno Therapeutics Inc.'s CAGE code?
Soleno Therapeutics Inc.'s CAGE code is 72XA4, and its Unique Entity ID (UEI) is DA8ADMFJRDU9.
Which contract vehicles does Soleno Therapeutics Inc. hold?
Soleno Therapeutics Inc. holds a place on 1 federal contract vehicle: FSS-61-IB.
What is Soleno Therapeutics Inc.'s most recent federal award?
Soleno Therapeutics Inc.'s most recent federal grant award is Point of care breath test to screen for sickle cell disease in developing nations (R44HL126469), from National Heart Lung and Blood Institute (NIH), on August 21, 2017.
On GovTribe
See Soleno Therapeutics Inc.'s full federal record
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors